Joseph Scheeren - Net Worth and Insider Trading
Joseph Scheeren Net Worth
The estimated net worth of Joseph Scheeren is at least $22,673 dollars as of 2024-12-01. Joseph Scheeren is the Director of Barinthus Biotherapeutics PLC and owns about 23,000 shares of Barinthus Biotherapeutics PLC (BRNS) stock worth over $22,673. Details can be seen in Joseph Scheeren's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph Scheeren has not made any transactions after 2023-06-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph Scheeren
Joseph Scheeren Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph Scheeren owns 1 companies in total, including Barinthus Biotherapeutics PLC (BRNS) .
Click here to see the complete history of Joseph Scheeren’s form 4 insider trades.
Insider Ownership Summary of Joseph Scheeren
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BRNS | Barinthus Biotherapeutics PLC | 2023-06-26 | director |
Joseph Scheeren Latest Holdings Summary
Joseph Scheeren currently owns a total of 1 stock. Joseph Scheeren owns 23,000 shares of Barinthus Biotherapeutics PLC (BRNS) as of June 26, 2023, with a value of $22,673.
Latest Holdings of Joseph Scheeren
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BRNS | Barinthus Biotherapeutics PLC | 2023-06-26 | 23,000 | 0.99 | 22,673 |
Holding Weightings of Joseph Scheeren
Joseph Scheeren Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph Scheeren has made a total of 2 transactions in Barinthus Biotherapeutics PLC (BRNS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Barinthus Biotherapeutics PLC is the acquisition of 10,000 shares on June 26, 2023, which cost Joseph Scheeren around $24,400.
Insider Trading History of Joseph Scheeren
- 1
Joseph Scheeren Trading Performance
GuruFocus tracks the stock performance after each of Joseph Scheeren's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph Scheeren is 17.22%. GuruFocus also compares Joseph Scheeren's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph Scheeren within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joseph Scheeren's insider trading performs compared to the benchmark.
Performance of Joseph Scheeren
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.36 | | | | | |
| Relative Return to S&P 500(%) | -1.18 | | | | | |
Joseph Scheeren Ownership Network
Joseph Scheeren Owned Company Details
What does Barinthus Biotherapeutics PLC do?
Who are the key executives at Barinthus Biotherapeutics PLC?
Joseph Scheeren is the director of Barinthus Biotherapeutics PLC. Other key executives at Barinthus Biotherapeutics PLC include director & Chief Executive Officer William Enright , Chief Scientific Officer Nadege Pelletier , and Chief Financial Officer Gemma Brown .
Barinthus Biotherapeutics PLC (BRNS) Insider Trades Summary
Over the past 18 months, Joseph Scheeren made 1 insider transaction in Barinthus Biotherapeutics PLC (BRNS) with a net purchase of 10,000.
In summary, during the past 3 months, insiders sold 0 shares of Barinthus Biotherapeutics PLC (BRNS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Barinthus Biotherapeutics PLC (BRNS) were sold and 10,000 shares were bought by its insiders, resulting in a net purchase of 10,000 shares.
Barinthus Biotherapeutics PLC (BRNS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Barinthus Biotherapeutics PLC Insider Transactions
Joseph Scheeren Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph Scheeren. You might contact Joseph Scheeren via mailing address: The Schrodinger Building, Heatley Road, The Oxford Science Park, Oxford X0 Ox4 4ge.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
